New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay
New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay
Stay updated with breaking news from Ted Kyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds
New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications.
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions of older Americans.
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.